About Palmitoyltransferase ZDHHC16
Palmitoyltransferase ZDHHC16 (ZDHHC16) is a protein
from Homo sapiens identified by UniProt accession
Q969W1, 377 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Palmitoyltransferase ZDHHC16 |
| UniProt accession | Q969W1 |
| Gene | ZDHHC16 |
| Organism | Homo sapiens |
| Length | 377 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- serum alanine aminotransferase measurement · score 0.09
- serum gamma-glutamyl transferase measurement · score 0.08
- BMI-adjusted waist circumference · score 0.07
- hypertrophic cardiomyopathy · score 0.06
- Arrhythmogenic right ventricular dysplasia · score 0.04
- cardiomyopathy, dilated, 2G · score 0.04
- dilated cardiomyopathy 1AA · score 0.04
- myopathy, distal, 7, adult-onset, X-linked · score 0.04
- melorheostosis · score 0.04
- hypertrophic cardiomyopathy 6 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969W1-F1 | alphafold | PREDICTED | 87.67 | — |
Amino-acid sequence (377 residues)
MRGQRSLLLG PARLCLRLLL LLGYRRRCPP LLRGLVQRWR YGKVCLRSLL YNSFGGSDTA VDAAFEPVYW LVDNVIRWFG VVFVVLVIVL TGSIVAIAYL CVLPLILRTY SVPRLCWHFF YSHWNLILIV FHYYQAITTP PGYPPQGRND IATVSICKKC IYPKPARTHH CSICNRCVLK MDHHCPWLNN CVGHYNHRYF FSFCFFMTLG CVYCSYGSWD LFREAYAAIE KMKQLDKNKL QAVANQTYHQ TPPPTFSFRE RMTHKSLVYL WFLCSSVALA LGALTVWHAV LISRGETSIE RHINKKERRR LQAKGRVFRN PYNYGCLDNW KVFLGVDTGR HWLTRVLLPS SHLPHGNGMS WEPPPWVTAH SASVMAV
Explore Palmitoyltransferase ZDHHC16 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets